Pfizer Inc. (PFE): Why Are Hedge Funds Bullish on This Diabetes Stock Now?
Pfizer (PFE.US) and Biontech (BNTX.US) have announced positive results for their influenza mRNA vaccine.
mRNA technology can achieve fast and large-scale vaccine production.
Why Pfizer Stock Slumped on Friday
Pfizer and BioNTech's Covid-19/flu Combination Vaccine Falters in Phase III Readout
Pfizer Options Spot-On: On August 16th, 232.81K Contracts Were Traded, With 3.05 Million Open Interest
Pfizer, BioNTech Hit Roadblock in COVID-flu Vaccine Trial
Top Midday Decliners
Unusual Options Activity: CRWD, GEV and Others Attract Market Bets, CRWD V/OI Ratio Reaches 70.8
Express News | Pfizer Shares Down 2.2% After Co's Flu-Covid Combination Shot Misses One of the Main Goals in a Late-Stage Study
The Pfizer COVID/flu combination vaccine performed poorly in later trials and lags behind competitors.
Compared with standard influenza vaccine, the combination vaccine elicits a strong immune response to influenza A, but cannot provide effective immune protection against influenza B. Pfizer recruited more than 8,000 adults aged 18 to 64 to evaluate the safety, tolerability, and efficacy of the combination vaccine, and no safety issues were found.
Sector Update: Health Care Stocks Lean Lower Premarket Friday
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
Sector Update: Health Care
Pfizer, BioNTech's Combined Flu-Covid-19 Shot Misses Late-Stage Study Goal
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Pfizer, BioNTech Post Partial Win in Late-stage Trial for COVID/flu Combo Shot
BioNTech-Pfizer Vaccine Shows Mixed Trial Results
Pfizer, BioNTech Say Influenza Vaccine Candidate Met One of Two Primary Objectives in Phase 3 Trial
Express News | Pfizer - Companies Are Evaluating Adjustments to Combination Vaccine Candidate Aimed at Improving Immune Responses Against Influenza B and Will Discuss Next Steps With Health Authorities